Blood Transfusion Diagnostics Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The global blood transfusion diagnostics market is expected to witness a CAGR of ~7% during the forecast period. Blood transfusion diagnostics are the devices that are used to conduct tests before the transfusion of blood from donor to patient such as blood grouping disease screening. The main types of blood transfusion diagnostics are instruments and kits, reagents, and others. The blood transfusion diagnostic kits are used to collect and transfuse blood. There are some technologies of blood transfusion such as western blot, ELISA, nucleic acid amplification, fluorescence assay, and rapid test that are used for various applications such as blood grouping and disease screening. Furthermore, patients undergoing the surgical process need a blood transfusion to recover the blood lost in the body during the surgical process. Blood transfusion diagnostics are used during the process to monitor and diagnose the blood before transferring it to the patient’s body otherwise it will cause infectious diseases. According to the National Institutes of Health (NIH), approx. 310 million surgeries are being performed each year in the U.S.

Download Free Sample of this Report – https://univdatos.com/get-a-free-sample-form-php/?product_id=21049

According to UnivDatos Market Insights (UMI)’ research report “Blood Transfusion Diagnostics Market”, the market is expected to witness a CAGR growth of around ~7% during the forecast period 2021-2027F. 

Based on product type, the blood transfusion diagnostics market is segmented into reagents & kits and instruments. In 2020, The reagents and kits category is anticipated to witness a considerable growth rate over the forecast period owing to the increasing need for donor screening to prevent patients from unsuitable blood and blood products and combat TTIs. Furthermore, the rising prevalence of chronic and infectious diseases such as severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, and thrombocytopenia and the introduction of technologically advanced products are among the factors driving the demand for reagents & kits.

 

Based on application, the blood transfusion diagnostics market has been segmented into blood grouping, and disease screening. In 2020, the Disease Screening category held the largest share and is anticipated to witness a considerable growth rate over the forecast period. The rising incidence of TTI worldwide, increasing safety screening of donated blood, and safe transfusion, are some of the key factors driving the market. In addition, numerous countries, including the UAE, South Africa, and the U.S., have made TTI testing a mandatory protocol.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21049

Based on end-user, the market is bifurcated into hospitals, blood banks, diagnostic laboratories, and others. In 2020, the blood bank category accounted for the majority share in the global market. This is due to many disease screening and blood typing services performed before transfusion therapy, in these facilities. Furthermore, stringent regulations related to maintaining the safety of blood supply through disease screening is further driving the market. Some of the standard tests performed in these end-use settings with the donated blood include blood typing, Rh typing, unexpected RBC antibody screening, and infectious disease screening

 

North America to witness extensive growth

For a better understanding of the market, the report provides a detailed analysis of major regions and countries including North America (U.S., Canada, Rest of America); Europe (Germany, U.K., France, Spain, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific) and Rest of World. In 2020, North America accounted for the significant market share. This can be attributed to the Increasing health awareness, high disposable income, favorable reimbursement policies, and well-established healthcare infrastructure are some of the key factors boosting the regional market. According to Community Blood Center data, every day around 43,000 pints of donated blood is used in both the U.S. and Canada. According to Community Blood Center (CBC) data, every day around 43,000 pints of donated blood is used in both the U.S. and Canada.

For more informative information, please visit us – https://univdatos.com/report/blood-transfusion-diagnostics-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the blood transfusion diagnostics market are Immucor, Inc., Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Quotient Limited, BAG Healthcare GmbH, DiaSorin S.P.A., Danaher, BIO KIT (Werfen) Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions. 

“Blood Transfusion Diagnostics Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.      

For more informative information, please visit us – https://univdatos.com/report/blood-transfusion-diagnostics-market/

Market Segmentation:

1.      By Product (Reagents & Kits, Instruments)

2.      By Application (Blood Grouping, Disease Screening {Serological Disease Screening and Molecular Disease Screening})

3.      By End-User (Hospitals, Blood Banks, Diagnostic Laboratories, and Others)

4.      By Company (Immucor, Inc., Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Quotient Limited, BAG Healthcare GmbH, DiaSorin S.P.A., Danaher, BIO KIT (Werfen))

Key questions answered in the study:

1.      What are the current and future trends of the blood transfusion diagnostics industry?

2.      How the industry has been evolving in terms of technology and application?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the blood transfusion diagnostics industry?

5.      What is the customer orientation, purchase behavior, and expectations from the blood transfusion diagnostics suppliers across various region and countries?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 BLOOD TRANSFUSION DIAGNOSTICS MARKET COVID-19 IMPACT

6 BLOOD TRANSFUSION DIAGNOSTICS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

8 MARKET INSIGHTS BY APPLICATION

9 MARKET INSIGHTS BY END-USER

10 MARKET INSIGHTS BY REGION

11 BLOOD TRANSFUSION DIAGNOSTICS MARKET DYNAMICS

12 BLOOD TRANSFUSION DIAGNOSTICS MARKET OPPORTUNITIES

13 BLOOD TRANSFUSION DIAGNOSTICS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        Heart Pump Devices Market to exceed US$ 6 Billion by 2027 Globally | CAGR: 18.9% |

·        Middle East & Africa (MEA) Pharmaceutical Packaging Market will reach to US$ 13,265.7 Mn by 2028|CAGR: 8% |

·        GCC E-Pharmacy Market to Reach US$ 5,347.6 Million by 2028 | CAGR: 15.4%|

·        MEA IVF Tools and Techniques Market to Reach US$ 3,164.7 Million by 2027 |CAGR: 16.3%|